DURHAM, N.C.--(BUSINESS WIRE)--Bioventus, a global leader in orthobiologic solutions, today announced it has entered into a multi-year agreement with IBSA (Institut Biochimique SA), a pharmaceutical ...
DURHAM, N.C.--(BUSINESS WIRE)--Beginning January 1, 2020 Bioventus, a global leader in orthobiologic solutions, has secured preferred access for Blue Cross Blue Shield of Michigan Medicare Advantage ...
Sodium hyaluronate 0.84%; per 2mL; soln for intra-articular inj. Do not inject by intravascular route. Severe intra-articular effusion. Lymphatic or venous stasis in leg. Advise patients to avoid ...
Bioventus announced the availability of Gelsyn-3 (hyaluronic acid), an injectable indicated for pain associated with osteoarthritis of the knee. Bioventus announced the availability of Gelsyn-3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results